Clinical Trial Update: Vorinostat Plus Radiation Therapy in Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated vorinostat in combination with radiation therapy for pancreatic cancer; the study was terminated and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-02-24